MedPath

Effect of Melatonin on prevention of delirium

Phase 2
Conditions
Delirium.
Delirium due to known physiological condition
Registration Number
IRCT20100816004578N8
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Ages 17 to 70 years
Having the power of communication
RASS score equal to or greater than -3
Hospitalized for at least seven days in ICU ward

Exclusion Criteria

Vision and hearing problems
History of mental disorders such as psychosis and mental retardation
History of antipsychotic medication use

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delirium incidence. Timepoint: Daily. Method of measurement: Confusion Assessment Method for the ICU (CAM-ICU); Intensive Care Delirium Screening Checklist (ICDSC).
Secondary Outcome Measures
NameTimeMethod
umber of admission days. Timepoint: after discharge from hospital. Method of measurement: patient's records.
© Copyright 2025. All Rights Reserved by MedPath